Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03496766
Title Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Spanish Lung Cancer Group
Indications

lung squamous cell carcinoma

Therapies

Tipifarnib

Age Groups: adult | child | senior
Covered Countries

Additional content available in CKB BOOST